Award
Delivery Order #SPE2D326F6616
Delivery Order for Ketorolac Vials to DoD from Fresenius Kabi
Buyer
Defense Logistics Agency
Award Amount
$426.28
Ceiling
$426.28
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 27, 2026
Identifier
SPE2D326F6616
NAICS
325411
This award represents a delivery order contract under an existing indefinite delivery/indefinite quantity (ID/IQ) contract awarded to Fresenius Kabi, LLC, a company specializing in pharmaceutical manufacturing and distribution. The contract involves the procurement of Ketorolac 30 MG/ML vials, a critical pharmaceutical product used for pain management. This delivery order supports the Department of Defense's continued need for essential medical supplies to maintain operational readiness and effective healthcare for military personnel. The scope includes the delivery of specified pharmaceutical vials within a short performance period. The order was placed as part of a competitive and ongoing procurement strategy under a broader, long-term contract awarded through competitive means to ensure reliable supply. The contract's timeline covers a brief, multi-day delivery window, aligning with the need for timely replenishment of medical stock. This delivery order is linked to a significant parent indefinite delivery contract that secures critical medical supplies for the U.S. Armed Forces, highlighting its role within a large-scale, multi-year supply framework.
Description
4571025535!KETOROLAC 30 MG/ML VIALML